Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes Patients
Status:
Withdrawn
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The study aims to see if there is any significant difference in the cardiovascular outcomes
in type 2 diabetes patients who are treated with pioglitazone or Metformin
Phase:
Phase 4
Details
Lead Sponsor:
Postgraduate Institute of Medical Education and Research
Collaborator:
Council of Scientific and Industrial Research, India